AB InBev brands seeing fast growth in the U.S., CEO says
Michel Doukeris, CEO of the world's largest brewer Anheuser-Busch InBev, discusses the firm's full year earnings.
Budweiser's parent company is selling less beer and making more money
The maker of Budweiser increased prices and operated more efficiently.
Bud Stock Jumps. Why AB InBev Revenue Rose Despite Consumers Shunning Beer.
AB InBev said its Michelob Ultra brand gained more U.S. market share than any other beer over the second half of 2024.
AB InBev beats revenue estimates as premium and non-beer sales offset declining beer demand
Anheuser-Busch InBev (AB InBev), the world's largest brewer, delivered stronger-than-expected fourth-quarter revenue, defying concerns over declining global beer demand. The company reported a 3.4% year-over-year revenue increase to $14.84 billion, surpassing analysts' estimates of $14.05 billion.
AB InBev toast record FY revenue
The world's largest brewer, AB InBev posts record FY revenue but overall volumes fall. Washington and Kyiv are reportedly set to sign an agreement over critical mineral resources in Ukraine in exchange for yet unspecified U.S. support measures.
Brewer AB InBev's profits jump, but China beer sales falter
Beer giant Anheuser-Busch InBev on Wednesday reported forecast-beating fourth quarter profits, even as a slowdown in the Chinese beer market dragged volumes down.
Are These 5 Beverage Stocks Poised for Earnings Beat This Season?
The beverage industry players are expected to have gained from expansion, pricing and solid demand, but inflation and currency woes are likely to have posed challenges.
AB InBev's Q4 Earnings on Deck: What Surprise Awaits Investors?
BUD's fourth-quarter 2024 results are likely to show the impacts of challenging macroeconomic conditions and higher expenses.
Seeking Clues to Anheuser-Busch Inbev (BUD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Evaluate the expected performance of Anheuser-Busch Inbev (BUD) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Anheuser-Busch InBev: Making A U-Turn On My Initial Thesis (Rating Upgrade)
Anheuser-Busch InBev stock's performance has been a disaster for shareholders in recent years. After keeping my 'Sell' rating on the stock for a number of years, I am now optimistic that BUD could deliver satisfactory shareholder returns. I take a closer look at the Company's pricing within the context of ongoing improvements within the business, and I outline my reasoning for assigning a Buy rating.
BUD vs. DEO: Which Stock Has More Spirit?
We think that Anheuser-Busch InBev stock (NYSE: BUD) is currently a better pick over its peer, Diageo stock (NYSE: DEO). BUD stock trades at 1.6x trailing revenues, versus 3.3x for DEO.
Is Anheuser-Busch InBev A Contrarian Buy Near Pandemic Bottoms?
BUD continues to face a lack of bullish support, thanks to the numerous headwinds across FX devaluation, declining alcohol volumes sold on YoY basis, and potential cancer label. The industry's secular decline may also be attributed to the growing acceptance/availability of cannabis and higher demand for zero-proof/healthier alcohol. Even so, BUD has been reporting sequentially growing volumes sold since FQ1'24, with the expanding adj EBITDA also underscoring its ongoing reversal.
